HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Elizabeth J Davis Selected Research
Elizabeth J Davis Research Topics
Disease
14
Neoplasms (Cancer)
03/2024 - 01/2016
8
Melanoma (Melanoma, Malignant)
02/2021 - 05/2017
5
Sarcoma (Soft Tissue Sarcoma)
09/2023 - 09/2015
2
Fatigue
03/2024 - 01/2022
2
Nausea
03/2024 - 01/2022
2
Neoplasm Metastasis (Metastasis)
09/2022 - 07/2019
1
Pneumonia (Pneumonitis)
03/2024
1
Alopecia (Baldness)
03/2024
1
Constipation
03/2024
1
Diarrhea
03/2024
1
Epithelioid Hemangioendothelioma
03/2024
1
Edema (Dropsy)
03/2024
1
Exanthema (Rash)
03/2024
1
Vomiting
03/2024
1
Pain (Aches)
03/2024
1
Alveolar Soft Part Sarcoma
09/2023
1
Body Weight (Weight, Body)
09/2023
1
Osteosarcoma (Osteogenic Sarcoma)
05/2023
1
Perivascular Epithelioid Cell Neoplasms
10/2022
1
COVID-19
09/2022
1
Liposarcoma
01/2022
1
Leiomyosarcoma
01/2022
1
Hemangiosarcoma (Angiosarcoma)
03/2021
1
Renal Cell Carcinoma (Grawitz Tumor)
02/2021
1
Disease Progression
01/2020
1
Drug-Related Side Effects and Adverse Reactions
01/2019
1
Aplastic Anemia (Anemia, Hypoplastic)
01/2019
1
Hemolytic Anemia
01/2019
1
Pure Red-Cell Aplasia
01/2019
1
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2019
1
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2019
1
Synovial Sarcoma (Synovioma)
08/2018
1
Adenocarcinoma
01/2018
1
Carcinoma (Carcinomatosis)
05/2017
1
Rectal Neoplasms (Rectal Cancer)
09/2014
1
Urinary Bladder Neoplasms (Bladder Cancer)
09/2014
1
Chronic Pain
01/2011
1
Glaucoma
10/2009
Drug/Important Bio-Agent (IBA)
4
Immune Checkpoint Inhibitors
IBA
01/2020 - 01/2018
3
Gemcitabine
FDA Link
08/2018 - 09/2015
2
Ligands
IBA
01/2021 - 12/2018
2
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2020 - 07/2019
2
Ipilimumab
IBA
01/2020 - 07/2019
2
Biomarkers (Surrogate Marker)
IBA
01/2020 - 01/2016
2
Docetaxel (Taxotere)
FDA Link
08/2018 - 09/2015
1
Opiate Alkaloids
IBA
03/2024
1
trametinib
IBA
03/2024
1
atezolizumab
IBA
09/2023
1
trans-sodium crocetinate (crocetin)
IBA
10/2022
1
Monoclonal Antibodies
IBA
10/2022
1
Immunoglobulins (Immunoglobulin)
IBA
10/2022
1
selinexor
IBA
01/2022
1
Paclitaxel (Taxol)
FDA Link
Generic
03/2021
1
Interleukin-2 (IL2)
IBA
02/2021
1
Steroids
IBA
01/2020
1
Nivolumab
IBA
01/2020
1
Blocking Antibodies
IBA
01/2020
1
Programmed Cell Death 1 Receptor
IBA
01/2020
1
Proteins (Proteins, Gene)
FDA Link
01/2020
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
11/2019
1
Inosine Triphosphate (ITP)
IBA
01/2019
1
Platinum
IBA
01/2018
1
Fluorouracil (Carac)
FDA Link
Generic
01/2018
1
Cisplatin (Platino)
FDA Link
Generic
01/2018
1
DNA (Deoxyribonucleic Acid)
IBA
03/2017
1
RNA (Ribonucleic Acid)
IBA
03/2017
1
olaratumab
IBA
01/2017
1
Cysteine (L-Cysteine)
FDA Link
01/2016
1
Glycoproteins (Glycoprotein)
IBA
01/2016
1
Blood Proteins (Serum Proteins)
IBA
01/2016
1
Ifosfamide
FDA Link
Generic
09/2015
1
Doxorubicin (Adriamycin)
FDA Link
Generic
09/2015
1
Opioid Analgesics (Opioids)
IBA
01/2011
Therapy/Procedure
15
Therapeutics
09/2023 - 10/2009
3
Drug Therapy (Chemotherapy)
08/2018 - 01/2016
2
Radiotherapy
03/2021 - 09/2014
1
Chemoradiotherapy
03/2021
1
Adjuvant Chemotherapy
01/2016